Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPICILLIN vs AMPICILLIN\SULBACTAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPICILLIN vs AMPICILLIN\SULBACTAM: Safety Overview

Metric AMPICILLIN AMPICILLIN\SULBACTAM
Total FAERS Reports 3,653 1,655
Deaths Reported 482 308
Death Rate 13.2% 18.6%
Hospitalizations 1,227 791
Average Patient Age 45.1 yrs 55.5 yrs
% Female Patients 65.6% 45.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Meitheal Pharmaceuticals Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A